Advanced Photonix Ships Pre-Production Versions of 100G High-Speed Optical Receivers

Picometrix, LLC, an Advanced Photonix company (NYSE Amex: API), announced today that it has added a second shift for hybrid assembly of its 40G NRZ client side, 40G DPSK and DQPSK lines of high-speed optical receivers (HSOR). Picometrix offers the industry's most complete line of 40G High-Speed Optical Receiver solutions for both client side and line side modulation formats, including NRZ, RZ, DPSK, DQPSK, ODB and DP-QPSK.

The Company also announced that it is shipping pre-production versions of its 100G line of high-speed optical receivers. The patented photodiodes and proprietary amplifiers utilized in these receivers deliver industry leading performance and reflect the Company's continued technology leadership in 40G and emerging 100G HSORs.

"Demand for Voice, Internet, HDTV, and Wireless requires increased bandwidth and increased speed including telecom infrastructure expansion for 10G, 40G and 100G requirements and both 40G and 100G line side products serve their respective market niche in the network infrastructure," said Richard (Rick) Kurtz President and CEO of API. "100G line side product adoption is being accelerated by demands to interconnect large data centers, like those at Google and Facebook. Traditional service providers are still in the early stages of evolving their networks to handle the demands of high definition video and delivery of content anytime, anywhere. These next generation wire line and wireless networks will require deployment of 40G and 100G to deliver this content, which is expected to grow annually by more than 25%. API's addition of the second shift is in response to this increase in demand for our high speed optical receivers, reflecting our leadership position."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.